These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 4458482)
1. The potentiation of the neuromuscular blocking activity of hexafluorenium and d-tubocurarine by volatile anaesthetics. Vermeer GA; Hess SW Anaesthesist; 1974 Feb; 23(2):72-8. PubMed ID: 4458482 [No Abstract] [Full Text] [Related]
2. Comparison in vitro of isoflurane and halothane potentiation of d-tubocurarine and succinylcholine neuromuscular blockades. Vitez TS; Miller RD; Eger EI; Van Nyhuis LS; Way WL Anesthesiology; 1974 Jul; 41(1):53-6. PubMed ID: 4834378 [No Abstract] [Full Text] [Related]
3. The interactions of hexafluorenium with depolarizing and competitive neuromuscular blocking agents. Scaf AH; van den Akker J; Berends F Arch Int Pharmacodyn Ther; 1974 Mar; 208(1):166-76. PubMed ID: 4276930 [No Abstract] [Full Text] [Related]
4. Hexafluorenium bromide: current status and a review. Britton RM; Figueroa M Anesth Analg; 1973; 52(1):100-5. PubMed ID: 4567515 [No Abstract] [Full Text] [Related]
5. The role of cholinesterase in the neuromuscular effects of succinylcholine, decamethonium and hexafluorenium. Scaf AH; van den Akker J; Westenberg HG Arch Int Pharmacodyn Ther; 1974 Mar; 208(1):177-92. PubMed ID: 4846189 [No Abstract] [Full Text] [Related]
6. Neuromuscular and electromyographic effects of halothane and its interaction with d-tubocurarine in man. Katz RL; Gissen AJ Anesthesiology; 1967; 28(3):564-7. PubMed ID: 4225766 [No Abstract] [Full Text] [Related]
7. The interactions of neuromuscular blocking agents in man: the role of hexafluorenium. Torda TA; Foldes FF; Bailey RJ; Klonymus DH; Kuwabara S Anesthesiology; 1967; 28(6):1010-9. PubMed ID: 4383425 [No Abstract] [Full Text] [Related]
8. Comparative neuromuscular effects of Forane and halothane alone and in combination with d-tubocurarine in man. Miller RD; Eger EI; Way WL; Stevens WC; Dolan WM Anesthesiology; 1971 Jul; 35(1):38-42. PubMed ID: 4932621 [No Abstract] [Full Text] [Related]
9. Effects of anaesthetics and their interactions with neuromuscular blocking agents in cats. Hughes R Br J Anaesth; 1970 Oct; 42(10):826-33. PubMed ID: 4248885 [No Abstract] [Full Text] [Related]
10. [Effect of ether and fluorothane on the comparative sensitivity of muscles to anatruxonium and D-tubocurarine chloride]. Lepakhin VK Farmakol Toksikol; 1970; 33(5):538-42. PubMed ID: 4321818 [No Abstract] [Full Text] [Related]
11. The effect of hexafluorenium on the neuromuscular refractory period of anesthetized man. Epstein RA; Jackson SH J Pharmacol Exp Ther; 1969 Nov; 170(1):153-6. PubMed ID: 5350999 [No Abstract] [Full Text] [Related]
12. Decrease in dose requirement of d-tubocurarine by volatile anesthetics. Waud BE Anesthesiology; 1979 Oct; 51(4):298-302. PubMed ID: 39476 [TBL] [Abstract][Full Text] [Related]
13. Time course of muscle relaxation with a combination of pancuronium and tubocurarine. Mirakhur RK; Pandit SK; Ferres CJ; Gibson FM Anesth Analg; 1984 Apr; 63(4):437-40. PubMed ID: 6703370 [TBL] [Abstract][Full Text] [Related]
14. The action of the aminoglycosidic antibiotic gentamicin of the isolated rat diaphragm. Potentiation of the neuromuscular blocking activity of gentamicin during combined application with muscle relaxant agents and magnesium. Paradelis AG; Triantaphyllidis C; Fidani V; Logaras G Arzneimittelforschung; 1974 Nov; 24(11):1774-9. PubMed ID: 4480048 [No Abstract] [Full Text] [Related]
15. The neuromuscular interaction of propanidid with suxamethonium and tubocurarine. Ellis FR Br J Anaesth; 1968 Nov; 40(11):818-24. PubMed ID: 5704350 [No Abstract] [Full Text] [Related]
16. THE EFFECTS OF HEXAFLUORENIUM AND EDROPHONIUM ON THE NEUROMUSCULAR BLOCKING ACTIONS OF SUCCINYLCHOLINE, DECAMETHONIUM, IMBRETIL AND D-TUBOCURARINE. KATZ RL; GISSEN AJ; KARIS JH Anesthesiology; 1965; 26():154-61. PubMed ID: 14261050 [No Abstract] [Full Text] [Related]
17. Steroidal monoquaternary ammonium salts with non-depolarizing neuromuscular blocking activity. Lewis JJ; Martin-Smith M; Muir TC; Ross HH J Pharm Pharmacol; 1967 Aug; 19(8):502-8. PubMed ID: 4382437 [No Abstract] [Full Text] [Related]